N@N

Market Maker Surveillance Report. EDAP, MEG, NRGY, CMED, MNEL, INFI, Losing Stocks With Lowest Price Friction For Friday, Janu

January 27, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 3481 companies with "abnormal" market making, 3734 companies with positive Friction Factors and 2270 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Friday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. EDAP TMS SA -ADR (NASDAQ:EDAP), MEDIA GENERAL INC -CL A (NYSE:MEG), INERGY, L.P. (NYSE:NRGY), CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED), MINNESOTA ELECTRS CO (NASDAQ:MNEL), Infinity Pharmaceuticals Inc (NASDAQ:INFI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     EDAP       $-0.310      -10.88%      32,131          29.00%       77,846          70.26%       -45,715         -1,475  
     MEG        $-1.100      -22.09%      188,152         32.50%       196,616         33.96%       -8,464          -77     
     NRGY       $-5.330      -23.50%      3,888,774       35.14%       4,276,650       38.64%       -387,876        -728    
     CMED       $-0.850      -23.16%      841,137         43.08%       1,001,793       51.31%       -160,656        -1,890  
     MNEL       $-0.680      -30.91%      204,164         45.51%       244,353         54.47%       -40,189         -591    
     INFI       $-3.970      -39.90%      995,464         43.63%       1,278,203       56.02%       -282,739        -712    

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows EDAP with a dollar loss Friday of $-0.31000 and a Friction Factor of -1,475 shares. That means that it only took 1,475 more shares of selling than buying to move EDAP lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

EDAP TMS SA -ADR (NASDAQ:EDAP) - EDAP TMS S.A. and its subsidiaries develop, produce, market, distribute, and maintain medical devices for the treatment of urological diseases. It operates in two divisions, High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of certain types of localized tumors using HIFU technology. The HIFU technology enables a surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division offers Ablatherm, an ultrasound guided HIFU device for the treatment of organ-confined prostate cancer. The UDS division produces and markets lithotripters devices for the treatment of urinary tract stones by using ESWL technology. This division manufactures three models of lithotripters: the Sonolith Praktis, the Sonolith Vision, and the Sonolith I-Sys. It also involves in leasing lithotripters, as well as offers disposables, spare parts, and maintenance services. EDAP TMS S.A. serves public and private hospitals, urology clinics, and research institutions. It markets and sells its products through direct marketing, service platform, and sales organization, as well as through third-party distributors and agents worldwide. The company was founded in 1979 and is based in Vaulx-en-Velin, France.

MEDIA GENERAL INC -CL A (NYSE:MEG) - Media General, Inc., a communications company, provides local news and information over various media platforms in small- and mid-size communities in southeastern United States. It owns 3 metropolitan and 20 community newspapers and 18 network-affiliated broadcast television stations. The company also owns approximately 200 weekly newspapers and other publications targeted at specific communities of interest. In addition, Media General operates Web sites affiliated with each of its newspapers and television stations. Further, it provides Blockdot, an advergaming business; Dealtaker.com, an online social shopping portal; and NetInformer, a mobile advertising and marketing service, as well as offers broadcast equipment and studio design services. The company has a strategic partnership with Yahoo, Inc. for content, search, and display advertising. Media General was founded in 1879 and is headquartered in Richmond, Virginia.

INERGY, L.P. (NYSE:NRGY) - Inergy, L.P. engages in retail marketing, sale, and distribution of propane to residential, commercial, industrial, and agricultural customers. The company serves approximately 800,000 retail customers from approximately 300 customer service centers in the United States. It also operates a natural gas storage business; a supply logistics, transportation, and wholesale marketing business, which serves independent dealers and multi-state marketers in the United States and Canada; and a solution-mining and salt production company. The company was formerly known as Inergy Holdings, L.P. and changed its name to Inergy, L.P. on November 06, 2010. Inergy, L.P. was founded in 1996 and is headquartered in Kansas City, Missouri.

CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED) - China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets advanced immunodiagnostic and molecular diagnostic products primarily in the Peoples Republic of China. The company offers IVD products, which utilize ECLIA technology, fluorescent in situ hybridization (FISH) technology, and surface plasmon resonance (SPR) technology to detect and monitor various diseases and disorders through the laboratory evaluation and analysis of blood, urine, or other body fluids. It offers ECLIA system, which includes ECLIA analyzer for detecting the minute levels of light triggered by combining reagents with body fluid samples to produce diagnostic results; and reagent kits for detecting and monitoring various types of diseases and disorders, including thyroid disorders, diabetes, hepatitis, SARS, Down syndrome, liver fibrosis, disorders related to reproduction and growth, and various types of tumors. The company also provides FISH imaging analysis system that enables medical practitioners to visualize and locate DNA sequences in human cells for identifying chromosomal abnormalities, using FISH technology; and offers FISH probes used for prenatal and cancer management. The FISH probes are used for the detection and monitoring the course of bladder cancer; treatment of breast cancer; prediction and diagnosis of cervical cancer; diagnosis and prognosis of various leukemias and multiple myeloma; detection of epidermal growth factor receptor abnormalities; detection of Trisomy 21, Trisomy 18, Trisomy 13, Turner syndrome, Trisomy X, XYY syndrome, DiGeorge syndrome, and triploidy; and diagnosis of prostate cancer. In addition, it offers HPV-DNA chips and SPR-based analysis system for the diagnosis of human papillomavirus (HPV) infection and genotyping of HPV. The company sells its products through distributors. China Medical Technologies, Inc. was founded in 1999 and is based in Beijing, the Peoples Republic of China.

MINNESOTA ELECTRS CO (NASDAQ:MNEL) - MINNESOTA ELECTRS CO

Infinity Pharmaceuticals Inc (NASDAQ:INFI) - Infinity Pharmaceuticals, Inc. engages in the discovery and development of medicines for the treatment of cancer and related conditions in the United States. Its lead product candidate includes IPI-504 (retaspimycin hydrochloride), an intravenously-administered small molecule inhibitor of heat shock protein 90 (Hsp90). The company is conducting an international Phase II clinical trial of IPI-504 in combination with Herceptin in patients with HER2-positive metastatic breast cancer; a Phase II clinical trial of IPI-504 in patients with advanced non-small cell lung cancer; and a Phase I clinical trial of IPI-504 in combination with Taxotere in patients with advanced solid tumors. Its products under Phase I clinical trial comprise IPI-493, an orally-delivered inhibitor of Hsp90, in patients with advanced solid tumors; IPI-926 for patients with advanced and/or metastatic solid tumors; and IPI-940, an orally-delivered inhibitor of fatty acid amide hydrolase for the treatment of neuropathic and inflammatory pain. Infinity Pharmaceuticals has strategic alliance agreements with Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Limited; an agreement with MedImmune, Inc. to develop and commercialize cancer drugs targeting Hsp90 and the hedgehog pathway; and a collaboration agreement with Novartis Institute for BioMedical Research, Inc. to discover, develop, and commercialize drugs targeting Bcl protein family members for the treatment of cancers. The company is headquartered in Cambridge, Massachusetts.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net